
WuXi Biologics Investor Relations Material
Latest events

H2 2024
WuXi Biologics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from WuXi Biologics (Cayman) Inc
Access all reports
WuXi Biologics (Cayman) Inc. is a global contract research, development, and manufacturing organization (CRDMO) focused on biologics. The company offers comprehensive services that span from biologic discovery and development to commercial manufacturing. Key offerings include protein generation, antibody development, assay development, and regulatory affairs. The company is headquartered in Wuxi, China, and its shares are listed on the Hong Kong Stock Exchange.
Key slides for WuXi Biologics (Cayman) Inc


H1 2024
WuXi Biologics (Cayman) Inc


H2 2024
WuXi Biologics (Cayman) Inc
Latest articles
)
Upcoming IPOs to Watch in 2025
Potential IPOs in 2025 include prominent names like Shein, Databricks, Klarna, eToro, and Figma, to name a few. Let's take a closer look.
23 May 2025
)
Figma: Collaborative Design Tool Ready for IPO
Figma, the popular design platform, is preparing for a potential IPO in 2025 as it continues to reshape the future of collaborative design.
22 May 2025
)
Companies That Had Their IPO in 2024: Momentum Increasing
2024 marked a steady year for IPOs, driven by strong markets, AI momentum, and high-profile listings across industries and regions.
22 May 2025
Ticker symbol
2269
Country
🇭🇰 Hong Kong